¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Cytarabine Liposome IT"¿¡ ´ëÇÑ ¿µ¿µ ÀÇÇлçÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
cytarabine <drug, oncology> A pyrimidine nucleoside analog that is used mainly in the treatment of leukaemia, especially acute non-lymphoblastic leukaemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the s phase of the cell cycle. It also has antiviral and immunosuppressant properties.
Pharmacological action: antimetabolite, antineoplastic, antiviral agent, immunosuppressive agent.
Chemical name: 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-
(12 Dec 1998)
liposome <biochemistry> A spherical particle in an aqueous medium, formed by a lipid bilayer enclosing an aqueous compartment.
Origin: Gr. Soma = body
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á